Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study.
Kuan V, Denaxas S, Patalay P, Nitsch D, Mathur R, Gonzalez-Izquierdo A, Sofat R, Partridge L, Roberts A, Wong ICK, Hingorani M, Chaturvedi N, Hemingway H, Hingorani AD; Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC). Kuan V, et al. Among authors: hingorani m, hingorani ad. Lancet Digit Health. 2023 Jan;5(1):e16-e27. doi: 10.1016/S2589-7500(22)00187-X. Epub 2022 Nov 29. Lancet Digit Health. 2023. PMID: 36460578 Free article.
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect.
Olvera-Barrios A, Rudnicka AR, Anderson J, Bolter L, Chambers R, Warwick AN, Welikala R, Fajtl J, Barman S, Remgnino P, Wu Y, Lee AY, Chew EY, Ferris FL, Hingorani A, Sofat R, A Egan C, Tufail A, Owen CG; ARIAS Research Group. Olvera-Barrios A, et al. Br J Ophthalmol. 2023 Nov 22;107(12):1839-1845. doi: 10.1136/bjo-2023-324097. Br J Ophthalmol. 2023. PMID: 37875374 Free PMC article.
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.
Olvera-Barrios A, Owen CG, Anderson J, Warwick AN, Chambers R, Bolter L, Wu Y, Welikala R, Fajtl J, Barman SA, Remagnino P, Chew EY, Ferris FL, Hingorani AD, Sofat R, Lee AY, Egan C, Tufail A, Rudnicka AR; ARIAS Research Group. Olvera-Barrios A, et al. Among authors: hingorani ad. BMJ Open Diabetes Res Care. 2023 Nov;11(6):e003683. doi: 10.1136/bmjdrc-2023-003683. BMJ Open Diabetes Res Care. 2023. PMID: 37949472 Free PMC article.
Prioritising genetic findings for drug target identification and validation.
Hukerikar N, Hingorani AD, Asselbergs FW, Finan C, Schmidt AF. Hukerikar N, et al. Among authors: hingorani ad. Atherosclerosis. 2024 Mar;390:117462. doi: 10.1016/j.atherosclerosis.2024.117462. Epub 2024 Jan 26. Atherosclerosis. 2024. PMID: 38325120 Free article. Review.
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
Prapiadou S, Živković L, Thorand B, George MJ, van der Laan SW, Malik R, Herder C, Koenig W, Ueland T, Kleveland O, Aukrust P, Gullestad L, Bernhagen J, Pasterkamp G, Peters A, Hingorani AD, Rosand J, Dichgans M, Anderson CD, Georgakis MK. Prapiadou S, et al. Among authors: hingorani ad. Circulation. 2024 Feb 27;149(9):669-683. doi: 10.1161/CIRCULATIONAHA.123.064974. Epub 2023 Dec 28. Circulation. 2024. PMID: 38152968 Free article.
316 results